Psychedelics
15 videos · updated daily
11:24 Minnesota Clinic Running Psychedelic Drug Trials
Dr. Manoj Doss, founder and CEO of the Institute for Integrative Therapies, tells FOX 9 about the Eden Prairie clinic's role in clinical trials testing psychedelic treatments for PTSD and depression and the race to develop FDA-approved psychedelic drugs.
33:43 Psychedelic Therapy Trials: Evidence and Methods
Psychiatrist and researcher Sandeep Nayak discusses psychedelic clinical trials, the methodological problems in the field, the FDA decision on MDMA and which research questions matter most, in an OPEN Foundation interview at ICPR.
22:12 FDA on Psychedelics, PDUFA Reauthorization and TrialBlazer
BioSpace covers an FDA public forum on psychedelic therapeutics, a meeting on reauthorizing the Prescription Drug User Fee Act, the agency's TrialBlazer initiative, and a late-stage trial result for Definium Therapeutics' LSD drug.
56:13 First-in-Human MEAI Trial: Yale & Johns Hopkins Researchers Discuss CMND-100
Investigators from Yale and Johns Hopkins, with Clearmind CEO Adi Zuloff-Shani, discuss the first-in-human trial of CMND-100, an MEAI-based compound for alcohol use disorder.
25:12 How Will FDA Regulate Psychedelics?
The Cancer Letter on the FDA's final guidance for sponsors running trials of psychedelics — psilocybin, LSD and MDMA — and what it means for psycho-oncology.
26:46 MDMA, Empathy, and Openness in Couples Therapy
Clinical psychologist Anne Wagner, founder of the Remedy Institute, discusses her trial of MDMA-assisted couples therapy for PTSD, including the trial process, exclusions, unblinding and the FDA decision on MDMA, in an OPEN Foundation interview at ICPR.
56:23 Psychedelics for IBS: Inside the First Clinical Trial with Erin Mauney, MD
Dr. Erin Mauney, a pediatric gastroenterologist and researcher at Harvard and Massachusetts General Hospital, on one of the first clinical trials of psilocybin-assisted therapy for patients with treatment-resistant IBS.
1:28 Clinical Trials For Generalized Anxiety Disorder Using LSD Like Drug
A Ft. Lauderdale research site is conducting clinical trials of a LSD-like drug to treat Generalized Anxiety Disorder.
39:34 Psychedelic Therapeutics from Chemistry to Clinical Trials
Sam Chuang, Director of Scientific Advisory Services at Charles River, and Susanne Back of Charles River discuss how second-generation psychedelic therapeutics are developed from chemistry through to clinical trials.
53:57 Early Clinical Trials with Psychedelics and PTSD From PBS
PBS looks at use of Psychedelics including Psilocybin and MDMA with a look at use of the drugs in treating depression in cancer patients and a clinical trial from MAPS using MDMA to to treat PTSD in a former US Soldier.
4:08 Johns Hopkins Medicine Studies Magic Mushrooms to Stop Smoking
A woman participated in a clinical trial at Johns Hopkins University to quit smoking using magic mushrooms, also known as psilocybin, and she stopped her 40-year smoking habit after taking psilocybin.
46:50 Psychedelics in the Treatment of Addictions
Matthew W. Johnson, associate professor of psychiatry and behavioral neurosciences at Johns Hopkins University, reviews research on classic psychedelics such as psilocybin for addiction treatment, from early LSD trials to contemporary clinical studies.
57:18 Researching Psilocybin Therapy: Challenges and Prospects
Josh Woolley, MD, PhD, of UC San Francisco discusses current challenges and future prospects in researching psilocybin therapy, at the 2023 UC Davis Psychedelic Summit, for UC Davis Health.
13:34 LSD for Anxiety? Study Finds One Dose Helps for Months
Dr. Josh Eloge, Associate Director at Rush’s Depression Treatment Research Center, joined "ChicagoNOW" to explain LSD research and where psychedelic therapy is headed.
4:27 Iraq War Veteran Says MDMA Saved His Life and Helped His PTSD
Iraq War Veteran participated in a clinical trial by MAPS of MDMA and the trial found 67% of patients who tried MDMA lost their PTSD symptoms.